Furthermore, the proportion of samples with detectable sFRα was greatest in patients with tumours where ≥50% cells expressed FRα on the membrane, and a trend for higher concentration of sFRα was observed in this group, compared to patients with 0–<25% positive tumour cells in tumour lesions (Fig. 4a, middle). Here, FOLR1 is linked to neoplasm.